13F filer · CIK 924223
BB BIOTECH AG
SCHAFFHAUSEN, V8 · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$2.5B
+$17.2M vs prior
Positions
30
New / sold out
3 / 2
Added / reduced
6 / 2
Turnover
2.6%
buys $89.3M · sells $66.3M
Top-10 weight
72.7%
Biggest buys vs Q1 2016
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | Intra-Cellular Therapies Inc. | +700,000 | – | +$27.2M |
| Added | Alexion Pharmaceuticals Inc. | +145,000 | +14.0% | +$16.9M |
| New | MacroGenics Inc. | +520,000 | – | +$14.0M |
| Added | Agios Pharmaceuticals Inc. | +203,400 | +9.4% | +$8.5M |
| Added | Ionis Pharmaceuticals Inc. | +325,000 | +4.8% | +$7.6M |
| New | Tobira Therapeutics Inc. | +468,000 | – | +$5.9M |
| Added | Alder Biopharmaceuticals Inc. | +175,000 | +11.6% | +$4.4M |
| Added | Vertex Pharmaceuticals Inc. | +50,000 | +3.7% | +$4.3M |
| Added | Sage Therapeutics Inc. | +16,976 | +2.0% | +$511.5K |
Biggest sells vs Q1 2016
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | Medivation Inc. | -590,000 | -22.9% | $-35.6M |
| Sold out | Infinity Pharmaceuticals Inc. | -2,700,737 | -100.0% | $-14.2M |
| Sold out | Clovis Oncology Inc. | -528,188 | -100.0% | $-10.1M |
| Reduced | Tesaro Inc. | -75,000 | -6.1% | $-6.3M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2016
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Celgene CorpCOM | 3,609,298 | $356.0M | 14.05% |
| 2 | Incyte Corp.COM | 3,840,406 | $307.2M | 12.12% |
| 3 | Gilead Sciences Inc.COM | 2,774,596 | $231.5M | 9.14% |
| 4 | Ionis Pharmaceuticals Inc.COM | 7,104,838 | $165.5M | 6.53% |
| 5 | Radius Health Inc.COM | 4,360,399 | $160.2M | 6.33% |
| 6 | Neurocrine Biosciences Inc.COM | 3,121,552 | $141.9M | 5.60% |
| 7 | Alexion Pharmaceuticals Inc.COM | 1,179,428 | $137.7M | 5.44% |
| 8 | Vertex Pharmaceuticals Inc.COM | 1,415,445 | $121.8M | 4.81% |
| 9 | Medivation Inc.COM | 1,991,112 | $120.1M | 4.74% |
| 10 | Agios Pharmaceuticals Inc.COM | 2,363,321 | $99.0M | 3.91% |
20 more rows. Subscribe for $29/month to see every row, download the data and use the API.